Jennerex therapy shrinks tumors in liver cancer patients

Jennerex's genetically modified smallpox vaccine shrunk tumors in liver cancer patients and extended survival by more than a year, a study shows. The company tested Pexa-Vec, the therapy treatment, on 30 individuals with advanced hepatocellular carcinoma. The 16 patients who received a high dose of Pexa-Vec lived a median of 14.1 months after injection, while the 14 who got a low dose lived a median of 6.7 months. More | Abstract

Source: http://www.fiercevaccines.com/story/jennerex-therapy-shrinks-tumors-liver-cancer-patients/2013-02-14?utm_source=rss&utm_medium=rss

hall of fame occupy dc ufc 143 fight card my fair lady conversion disorder the chronicle spinal stenosis